© 1995 American Heart Association, Inc.
Articles |
Higher Plasma Homocyst(e)ine and Increased Susceptibility to Adverse Effects of Low Folate in Early Familial Coronary Artery Disease
From Cardiovascular Genetics, Department of Internal Medicine, Cardiology Division (P.N.H., L.L.W., S.C.H., R.R.W.), the Department of Pathology, Associated Regional and University Pathologists (L.L.W., J.W.), Intermountain Health Care (B.C.J.), and the Cardiology Division, LDS Hospital (G.M.V.), University of Utah School of Medicine, Salt Lake City.
Abstract To examine the graded risks for coronary artery disease (CAD) associated with plasma homocyst(e)ine [H(e)] and to evaluate the extent to which this risk is mediated by altered vitamin status, we measured plasma concentrations of H(e), vitamins B6 and B12, and folate as well as other coronary risk factors in subjects with early familial CAD and in control subjects. We studied 120 male and 42 female patients with early CAD who were unrelated to each other but were from families in which at least one other sibling had early CAD. Control subjects were 85 men and 70 women with the same age range (38 to 68) as the subjects with CAD at screening. Increasing H(e) was associated with graded increased risks of CAD that appeared consistent with a multiplicative model. Relative odds for CAD were approximately 12.8 in women when those with H(e) levels of 19 µmol/L and above were compared with those with H(e) levels of 9 µmol/L or less (P=.007). For men, the same comparison yielded relative odds of 13.8 (P=.0002). Plasma H(e) remained a strong, independent risk factor after adjustment for standard risk factors and plasma vitamin levels in multiple logistic regression (relative odds, 8.1 for a 10-µmol/L increase in H(e); 95% confidence interval, 3.2 to 20.4; P<.0001). In multivariate ANCOVA the slope of H(e) versus folate was much steeper in subjects with CAD than in control subjects (P=.0035). These data suggest that high plasma H(e) is an important, independent contributor to risk for early familial CAD. Furthermore, subjects with early familial CAD who had low plasma folate levels had exaggerated elevations in plasma H(e), suggesting a possible genetic sensitivity to the detrimental effects of lower folate intake.
Key Words: plasma homocysteine • coronary heart disease • risk factors • genetics • folic acid
This article has been cited by other articles:
 |
|
 |
|
  H. N. Hodis, W. J. Mack, L. Dustin, P. R. Mahrer, S. P. Azen, R. Detrano, J. Selhub, P. Alaupovic, C.-r. Liu, C.-h. Liu, et al. High-Dose B Vitamin Supplementation and Progression of Subclinical Atherosclerosis: A Randomized Controlled Trial Stroke, March 1, 2009; 40(3): 730 - 736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Bosma, I. M. van der Meer, C. T. Bakker, A. Hofman, M. Paul-Abrahamse, and J. C. Witteman UGT1A1*28 Allele and Coronary Heart Disease: The Rotterdam Study Clin. Chem., July 1, 2003; 49(7): 1180 - 1181. [Full Text] [PDF]
|
|
|
|
 |
|
 Homocysteine Studies Collaboration Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis JAMA, October 23, 2002; 288(16): 2015 - 2022. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Weiss, C. Keller, U. Hoffmann, and J. Loscalzo Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia Vascular Medicine, August 1, 2002; 7(3): 227 - 239. [Abstract] [PDF]
|
|
|
|
 |
|
 E. S Ford, S J. Smith, D. F Stroup, K. K Steinberg, P. W Mueller, and S. B Thacker Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies Int. J. Epidemiol., February 1, 2002; 31(1): 59 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Brattstrom and D. E. Wilcken Homocysteine and cardiovascular disease: cause or effect? Am. J. Clinical Nutrition, August 1, 2000; 72(2): 315 - 323. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Eikelboom, E. Lonn, J. Genest Jr., G. Hankey, and S. Yusuf Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence Ann Intern Med, September 7, 1999; 131(5): 363 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. F. Jacques, J. Selhub, A. G. Bostom, P. W.F. Wilson, and I. H. Rosenberg The Effect of Folic Acid Fortification on Plasma Folate and Total Homocysteine Concentrations N. Engl. J. Med., May 13, 1999; 340(19): 1449 - 1454. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Malinow, A. G. Bostom, and R. M. Krauss Homocyst(e)ine, Diet, and Cardiovascular Diseases : A Statement for Healthcare Professionals From the Nutrition Committee, American Heart Association Circulation, January 12, 1999; 99(1): 178 - 182. [Full Text] [PDF]
|
|
|
|
|
|
D. W. Jacobsen Homocysteine and vitamins in cardiovascular disease Clin. Chem., August 1, 1998; 44(8): 1833 - 1843. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. N. Hopkins, L. L. Wu, S. C. Hunt, B. C. James, G. M. Vincent, and R. R. Williams Lipoprotein(a) Interactions With Lipid and Nonlipid Risk Factors in Early Familial Coronary Artery Disease Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2783 - 2792. [Abstract] [Full Text]
|
|
|
|
|
|
M.R. Malinow, F.J. Nieto, W.D. Kruger, P.B. Duell, D.L. Hess, R.A. Gluckman, P.C. Block, C.R. Holzgang, P.H. Anderson, D. Seltzer, et al. The Effects of Folic Acid Supplementation on Plasma Total Homocysteine Are Modulated by Multivitamin Use and Methylenetetrahydrofolate Reductase Genotypes Arterioscler Thromb Vasc Biol, June 1, 1997; 17(6): 1157 - 1162. [Abstract] [Full Text]
|
|
|
|
|
|
T. G. Deloughery, A. Evans, A. Sadeghi, J. McWilliams, W. D. Henner, L. M. Taylor, and R. D. Press Common Mutation in Methylenetetrahydrofolate Reductase: Correlation With Homocysteine Metabolism and Late-Onset Vascular Disease Circulation, December 15, 1996; 94(12): 3074 - 3078. [Abstract] [Full Text]
|
|
|
|
|
|
F. M.T. Loehrer, C. P. Angst, W. E. Haefeli, P. P. Jordan, R. Ritz, and B. Fowler Low Whole-Blood S-Adenosylmethionine and Correlation Between 5-Methyltetrahydrofolate and Homocysteine in Coronary Artery Disease Arterioscler Thromb Vasc Biol, June 1, 1996; 16(6): 727 - 733. [Abstract] [Full Text]
|
|
|
|
|
|
P. N. Hopkins, L. L. Wu, S. C. Hunt, B. C. James, G. M. Vincent, and R. R. Williams Higher Serum Bilirubin Is Associated With Decreased Risk for Early Familial Coronary Artery Disease Arterioscler Thromb Vasc Biol, February 1, 1996; 16(2): 250 - 255. [Abstract] [Full Text]
|
|